PTGER3 rs1409986: Obstructive Sleep Apnea Risk Explained
The rs1409986 variant is a single-nucleotide polymorphism located in an intronic region of the PTGER3 gene. Genome-wide association research has linked this variant to altered susceptibility to obstructive sleep apnea, maintaining this statistical association even after adjusting for body mass index. However, scientific evidence supporting this specific link remains limited, with associations largely restricted to specific European-ancestry cohorts.
What each genotype means
Baseline risk profile
This genotype represents the common genetic background at this location in the PTGER3 gene. Research indicates that individuals without the risk-associated allele may have a different statistical likelihood of obstructive sleep apnea compared to those who carry the variant, though the overall impact of this specific marker remains limited.
This is the most common genotype in many populations, though exact frequencies vary significantly by ancestry.
Increased sleep apnea association
Carrying one copy of the T allele has been associated in some studies with an increased statistical risk of obstructive sleep apnea in individuals of European ancestry. This association is observed independently of body mass index, suggesting a potential role for this gene in sleep-disordered breathing, though the clinical significance is considered limited.
Carried by a significant portion of the population, with the minor allele frequency typically ranging between 20% and 30% in European ancestry groups.
Elevated sleep apnea association
Individuals with two copies of the T allele may show a higher statistical association with obstructive sleep apnea compared to those with the C/C genotype. Because this evidence is based on population-level GWAS findings, it does not predict an individual diagnosis; please consult a healthcare provider if you have concerns about sleep quality or breathing.
This genotype is less common than the heterozygous state, occurring in roughly 4% to 9% of individuals in European ancestry populations.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs1409986 is located within an intron of the PTGER3 gene on human chromosome 1. Because it resides in a non-coding intronic region rather than an exon, it does not directly alter the amino acid sequence of the resulting protein. Instead, variants of this type typically function by modulating gene expression, altering alternative splicing patterns, or serving as genetic tags in linkage disequilibrium with other functional DNA changes nearby. In standard human reference assemblies, the locus alternates between common alleles, typically designated as adenine (A) and guanine (G) or thymine (T) and cytosine (C) depending on the strandedness of the genomic build. In public databases like dbSNP and the NHGRI-EBI GWAS Catalog, rs1409986 is cataloged as a common bi-allelic variant evaluated primarily in candidate locus and complex trait association studies.
Biological Role of the PTGER3 Gene
The PTGER3 gene encodes the prostaglandin E receptor 3, also commonly referred to as the EP3 receptor. This protein is a G-protein coupled receptor that binds prostaglandin E2 (PGE2), an essential lipid signaling molecule involved in diverse physiological cascades, including smooth muscle contraction, vascular tone regulation, immune modulation, and inflammation. In the respiratory and nervous systems, EP3 receptors are expressed across smooth muscle tissues, vascular beds, and neural pathways that govern airway reflexes and ventilatory control. Prostaglandin signaling is known to regulate mucosal inflammation, airway patency, and central respiratory drive. Consequently, biological disruption or altered regulation of PTGER3 expression has been hypothesized as a plausible pathway influencing airway collapsibility, local inflammatory swelling, or neural arousal thresholds during sleep.
Current Research and Strength of Evidence
Evidence linking rs1409986 to obstructive sleep apnea emerged primarily through large multi-cohort investigations, such as the Candidate-gene Association Resource (CARe) study. Researchers identified a statistically significant association between rs1409986 and obstructive sleep apnea in European-ancestry participants, showing that the correlation persisted independently of body mass index. Subsequent replication was reported in targeted clinic-based samples, including the Western Australian Sleep Health Study. Despite these positive findings, the overall strength of evidence is classified as limited. Complex traits like sleep apnea involve hundreds of contributing genetic loci interacting with lifestyle and anatomical factors. Because the association has not reached uniform genome-wide significance across larger multi-ancestry meta-analyses, rs1409986 should be regarded as a candidate research marker rather than a definitive predictor of disease.
Population Frequency and Ancestral Distribution
The distribution of alleles at rs1409986 varies notably across global populations documented in population databases like gnomAD and the 1000 Genomes Project. In cohorts of European ancestry, the minor allele displays a frequency generally ranging between 0.20 and 0.30, meaning that heterozygous carriers make up a substantial proportion of these populations. In contrast, frequency estimates differ across other ancestral groups, including populations of African, Asian, and Hispanic/Latino descent, where allele frequencies can diverge significantly. Furthermore, replication studies have revealed that the statistical association observed in European cohorts did not directly replicate in certain other ancestral groups, such as African-American cohorts, emphasizing the role of population-specific genetic architecture, differing linkage disequilibrium patterns, and environmental influences in complex sleep disorders.
Interpreting Genetic Data Responsibly
Discovering an association with rs1409986 provides educational context regarding genetic background but cannot diagnose or rule out obstructive sleep apnea. Having a risk-associated genotype does not mean an individual will inevitably develop airway obstruction during sleep, nor does carrying the baseline genotype guarantee protection. Obstructive sleep apnea is driven predominantly by established clinical risk factors, including upper airway anatomy, age, neck circumference, sleeping position, alcohol consumption, and metabolic health. Direct-to-consumer genetic findings should not be used to guide self-treatment, purchase dental appliances, or alter medical therapies. Individuals who experience hallmark symptoms of sleep apnea—such as loud snoring, witnessed breathing pauses, gasping, or persistent daytime sleepiness—should consult a certified sleep physician for formal evaluation via clinical polysomnography.
How common is this variant?
The minor allele at rs1409986 is common in European ancestry populations, with an estimated frequency between 0.20 and 0.30. Its prevalence varies across other global ancestries, where its association with sleep apnea has not been consistently demonstrated.
Frequently asked questions
Can rs1409986 determine if I have obstructive sleep apnea?
No. The rs1409986 variant is a statistical marker identified in population studies and is not a clinical test. Obstructive sleep apnea can only be diagnosed through an objective medical sleep study (polysomnography) supervised by a qualified healthcare professional.
Why is the association described as independent of body mass index?
While obesity is a primary clinical driver of airway collapse, researchers adjust for body mass index during statistical modeling to identify non-weight-related biological pathways. The persistence of the rs1409986 association after this adjustment suggests the PTGER3 pathway may influence tissue tone, local mucosal inflammation, or neural ventilatory reflexes rather than adiposity alone.
Is rs1409986 linked to medication responses?
Currently, rs1409986 is not included in clinical pharmacogenomic guidelines such as those from CPIC or PharmGKB. It does not have approved dosing recommendations for any sleep or respiratory medications, and any medication choices should always be discussed directly with your doctor or pharmacist.
Does carrying the risk allele mean I will definitely develop sleep apnea?
No. Obstructive sleep apnea is a polygenic, multifactorial condition governed by environmental factors, upper airway anatomy, age, and lifestyle habits alongside many genetic loci. Carrying one or two copies of this variant represents only a small statistical shift in relative risk across a broad population.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1409986?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29